Texas-based Phoenix Biotechnology, Inc. specializes in the development of safe and effective natural products for the treatment of human and animal disease. We are deeply committed to battling diseases with unmet needs in humans or with significant economic impact on commercial livestock health and to making our products widely available at low cost. Data developed to date justify further efforts toward development of therapies in the areas of cancer, virus mediated diseases, neuroprotection, and neurodegenerative diseases.
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo
Treatment of rhabdomyosarcoma (RMS), the most common a soft tissue sarcoma in childhood, provides intensive multimodal therapy, with radiotherapy (RT) playing a critical role for local tumor control. However, since RMS efficiently activates mechanisms of[read more]